Join
Live feed
·
INSIDERFilingvia Quantisnow
Insight Molecular Diagnostics Inc. logo

Chief Financial Officer James Andrea S. converted options into 50,000 shares, increasing direct ownership by 33% to 201,231 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IMDX· Insight Molecular Diagnostics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMDX (Insight Molecular Diagnostics Inc.) and more on Quantisnow.